Today Lori La Bey host of Alzheimer's Speaks Radio discusses the first Alzheimer's Research Trial where more than 40 academic and private clinics across the country come together to enroll hundreds of people living with mild to moderate Alzheimer's disease. Lori will be talking with Dr. Qureshi who is the executive director, of Neurology, at Biohaven pharmaceuticals and Dr. Leger a neurologist specializing in Alzheimer’s disease and who is an associate clinical professor, in Neuroscience at the University of California, San Diego. Both are involved with the new clinic trial called T2 Protect AD. Come join the conversation and learn about the study and how to get involved.
Contact Information for the T2 Protect AD Trial:
Additional Resources for Dementia and Caregiving
Initiatives and Projects